Di Emidio G, Rea F, Placidi M, et al
doi: 10.1016/j.ccr.2004.08.034 70 StackerSAWilliamsSPKarnezisTShayanRFoxSBAchenMG
Conclusion: Peptides for Long COVID Recovery Deserve Serious Clinical Attention Long COVID is real, biologically complex, and poorly served by the current standard of care for a significant proportion of patients
are preferably: Alizarin 5-amino-2-hydroxybenzoic acid, 3-aminophenol pyrocatechol, 2,2-bis (4-hydroxyphenyl) propane, bis (4-hydroxyphenyl) methane, quinalizarin, 4-chloro-1-naphthol, coniferyl alcohol , 2,4-diaminophenol dihydrochloride, 3,5-dichloro-4-hydroxyanin, 1,4-dimethylanthraquinone, 2,2-dihydroxybiphenyl, 4,4-dihydroxybiphenyl, 2,3- substances which have several hydroxyl groups such as: Eagic acid, GaUuic acid, GaUein, GaUangin, Myo-InositoL Morin, Nitranuklare, Phenolphthalein, Purpurin, PurpurogaUin, Quinizarin, Chrysazin, Quercitin, Quinhydron, Chloranuklare, Carmin, Rhodizonic acid, Croconic acid , Hematoxin, 9-phenyl-2,3,7-trihydroxy-6-fluorene, 9-methyl-2,3,7-trihydroxy-6-fluorene, tetrahydroxy-p-benzoquinone, 2,2'4,4'- Tetra-hydroxybenzophenone, PyrogaUol Red, 1-nitrophloroglucinoL 1,4-dihydroxyanthraquinone, 5,8-dihydroxy-1,4-naphthoquinone, hexaoxocyclohexanoctahydrate, 5,7 Appendix IV shows the formulas of mediators / mediation enhancers (NO, NOH and HNR-OH compounds) which can be used according to the invention as an additive to the enzyme component system (ECS) and which are used together with oxidoreductases, such as: Hydroxylamines Open-chain or cyclic, aliphatic or aromatic, heterocyclic of the general formula, N-hydroxymaleimide derivatives N-hydroxy-naphthalimide and optionally substituted N-hydroxy-naphthalimide derivatives, N-hydroxysuccinimides and optionally substituted N-hydroxysuccinimide derivatives such as: N-hydroxyphthalimide N-hydroxy-benzene-1,2,4-tricarboximide N, N'-dihydroxy-pyrome] acid diimide N, N-dihydroxy-benzophenone-3,3 ', 4,4'-tetracarboxylic acid cliimide, e.g
